1 We have studied the diuretic and natriuretic effects and the tubular site of action of nifedipine using free water clearance (CH20) and lithium clearance. 
Introduction
Calcium antagonists are potent antihypertensive drugs, which act through peripheral vasodilatation. They differ from traditional vasodilators by increasing renal water and sodium excretion (Zanchetti & Leonetti, 1985) , a feature noted by Klutsch et al. (1972) who treated hypertensive patients with nifedipine. More recently this diuretic and natriuretic capacity has been confirmed for a number of related calcium antagonists e.g. nifedipine (Ene et al., 1985) , nitrendipine (Ene etal., 1985; Wallia etal., 1985) , nicardipine (van Schaik et al., 1984) , and felodipine (Sluiter et al., 1985) . As reviewed elsewhere, several mechanisms could account for this natriuretic effect, and the tubular site of action is still debated (Zanchetti & Leonetti, 1985) . In rat studies using micropuncture techniques interference of calcium antagonists with sodium reabsorption in the distal tubule has been demonstrated (DiBona & Sawin, 1984) . In human studies data on the site of action of diuretic agents have to be obtained with indirect clearance techniques, mostly involving measurements of the fractional excretion of sodium and free water during maximal water diuresis (Seldin & Rector, 1972; Puschett, 1981) . Data obtained with these techniques should be interpreted with caution however, since there are several pitfalls when using this method (reviewed by Seldin & Rector, 1972) . Recently the use of lithium as a suitable marker of proximal tubular sodium transport has been proposed (Thomsen, 1984) . We (Seldin & Rector, 1972; see appendix Nifedipine caused a consistent rise of urinary flow rate ( Figure 1 ) reaching a maximum mean value of 22.5 ± 2.0 ml min-' in the third clearance 9.1 ± 1.0 9.0 ± 0.9 9.0 ± 0.9 8.8 ± 1.0 f 9.8 ± 0.7 9.7 ± 0.7 9.4 ± 0.6 9.1 ± 0.6 n 9.7 ± 1.0 11.5 ± 1.0* 11.4 ± 0.9** 11.4 ± 1. Figure   2 ). CH2O, however, did not change on frusemide (Figure 1) . The increased sodium excretion after frusemide administration was accompanied by an increased secretion of potassium as evidenced by the increased values of potassium clearance Time (min) Figure 1 Urinary flow rate and free water clearance (CH2O) after administration of placebo (*), nifedipine (m), or frusemide (A) at t = 0 min. Significant differences from placebo are marked. * P < 0.05; ** P < 0.01. 1.6 ± 0.3* 3.0 ± 1.0*t FeLi (%) 6.8 ± 1.6* 7.2 ± 1.5* CH2O (ml min-') 4.5 ± 0.9* 0.4 ± 0.7t
Urine flow (ml min') 7.4 ± 1.2* 3.9 ± 1.9
Values are given as means ± s.e. mean *;
Significantly different from placebo (P < 0.05). t; Significantly different from nifedipine (P < 0.05).
(CK) ( Table 1) . Fractional proximal sodium reabsorption and fractional distal sodium reabsorption corrected for distal sodium load were both decreased by frusemide (Table 1) . We additionally have analysed the mean maximal effects of nifedipine and frusemide using values of the period of the maximal natriuretic I 0 0 60 120 Time (min) Figure 2 Fractional excretion of Na and Li after administration of placebo (0), nifedipine (U), or frusemide (A) at t = 0 min. Significant differences from placebo are marked. * P < 0.05; ** P < 0.01.
effect of the drug for each volunteer, as compared with values in the same period on placebo. Results are given in Table 2 .
Discussion
We have studied the effects of nifedipine on renal excretory function in healthy volunteers, examined under conditions of maximal water diuresis. We have observed an evident increase of urinary flow rate and urinary sodium excretion, whereas urinary potassium excretion remained unchanged. These findings confirm our earlier observations with the related drug felodipine (Sluiter et al., 1985) , and agree with those of others who recently have demonstrated the diuretic and natriuretic properties of nitrendipine (Ene et al., 1985; Wallia et al., 1985) and nicardipine (van Schaik et al., 1984) . It is clear from our study that diuresis and natriuresis occur I despite the blood pressure lowering effect of the drug. In this respect calcium antagonists differ from traditional antihypertensive vasodilators, which almost invariably cause salt and water retention. Since a study of the possible mechanisms of the diuretic and natriuretic properties of nifedipine was beyond the scope of the current investigation, we did not perform extensive renal haemodynamic studies and have only used creatinine clearance as a marker of GFR. Nifedipine caused a transient increase in ECC, which is in agreement with our earlier studies on felodipine, which appeared to cause transient increases of ECC as well as of inulin clearance. Frusemide did not influence creatinine clearance, which is in agreement with studies of others who did not find any influence of frusemide on GFR using inulin clearance (Puschett & Goldberg, 1968) . Therefore, it seems unlikely that the use of creatinine clearance instead of inulin clearance could have substantially influenced our results.
We have used free water clearance as well as lithium clearance to elucidate the possible site of action of nifedipine. Free water clearance increased after nifedipine administration. A similar observation has been made by Wallia et al. (1985) and van Schaik et al. (1984) who studied the effects of nitrendipine, and nicardipine respectively during maximal water diuresis. An increase of free water clearance is generally viewed as evidence for interference with sodium reabsorption at a site proximal to the thick ascending limb of Henle's loop, e.g. the proximal tubule or the inner medullary segment of Henle's loop (Seldin & Rector, 1972; Puschett, 1981) . It is difficult, however, to draw firm conclusions, since this method has several pitfalls. The underlying assumption that the entire nephron distal from Henle's loop is completely water-impermeable during maximal water diuresis has been invalidated by results of animal studies (Morgan & Berliner, 1968; Jamison et al., 1971) . Theoretically, interference of a drug with water reabsorption in the collecting tubule could also explain the increased free water clearance, that we found.
To obviate this problem we have used lithium clearance in addition to free water clearance. As reviewed elsewhere, lithium could be a useful marker of proximal tubular sodium reabsorption (Thomsen, 1984) . Micropuncture studies in the rat have demonstrated that no lithium is reabsorbed beyond an early distal tubular puncture site (Hayslett & Kashgarian, 1979) . The increase in lithium excretion after administration of nifedipine is thus suggestive for interference of the drug with proximal tubular sodium reabsorption.
Taken together, both clearance methods indicate that the diuretic and natriuretic effect of nifedipine is established by inhibition of proximal tubular sodium reabsorption. However, the resultant increase in distal tubular flow rate and distal tubular sodium load did not cause an increased potassium excretion, as would have been expected (Good & Weight, 1979; Khuri et al., 1975) . This points to an additional interference of nifedipine with distal tubular function, specifically at the Na+-K+ exchange site. Blockade of the Na+-K+ exchange could explain the decrease in fractional distal sodium reabsorption (relative to distal tubular load).
In most animal studies the increase in sodium excretion after administration of calcium antagonists is accompanied by an increase in potassium excretion (DiBona & Sawin, 1984; Yamaguchi et al., 1974; Abe et al., 1982; Brown & Churchill, 1983) . These findings are compatible with a predominant proximal effect of these drugs, and suggest an absence of interference with Na+-K+ exchange. Interpretation is complicated by the apparently contradictory finding that in rats and dogs, using micropuncture techniques and stop flow procedures respectively, predominant interference of calcium antagonists with distal tubular sodium rebsorption has been demonstrated (DiBona & Sawin, 1984; Yamaguchi et al., 1974; Nagao etal., 1985) . We cannot explain these inconsistencies in the animal studies, but the effects of calcium antagonists may vary, depending on the experimental conditions, the type and dosage of the drug used, and the animal species studied.
Our data on frusemide agree with those in the literature. Although frusemide acts predominantly by inhibiting sodium reabsorption in the ascending limb of Henle's loop, an inhibitory effect on proximal tubular sodium transport has also been demonstrated (Puschett, 1981; Brenner et al., 1969) . This latter effect could be the result of the carbonic anhydrase inhibitory action of frusemide (Puschett & Goldberg, 1968) . This combined action on the proximal tubule and Henle's loop may explain why CH20 did not change in our study. Lithium clearance was increased by frusemide, in agreement with the observation of Steele et al. (1975) . This inhibitory effect of frusemide on lithium reabsorption could be the result of the above mentioned action of frusemide on proximal tubular sodium reabsorption.
Because of the inter-individual variability of changes after frusemide administration and the possible differences in gastro-intestinal absorption it is difficult to compare precisely the effects of nifedipine and frusemide. Therefore, we have analyzed the data, using values from the period of the maximal natriuretic effect in each volunteer (Table 2 ). When we compare the effects of nifedipine and frusemide on free water clearance it becomes clear that the drugs must have different sites of action. The increase in free water clearance after nifedipine administration favours a predominantly proximal site of action. Frusemide did not change free water clearance, which can be explained by a combined action on the proximal tubule and Henle's loop. In view of the differences between nifedipine and frusemide found with free water clearance technique, we would have expected to find a greater increase in lithium excretion after administration of nifedipine if lithium is only reabsorbed in the proximal tubule. Since we did not find differences in lithium excretion after nifedipine and frusemide administration, we feel that our data suggest that lithium is reabsorbed to an important degree in Henle's loop, a possibility also indicated by rat studies (Steele et al., 1976) . Lithium clearance per se may, therefore, be an imperfect marker of proximal tubular sodium reabsorption. From an ongoing study we have indications that the increase in lithium excretion corrected for the increase of sodium excretion may be a better marker in this respect. Indeed, when the ratio FeLi/FeNa was used to compare maximal nifedipine and frusemide effects in this study a significant difference became apparent (respectively 4.1 ± 0.4 and 2.9 ± 0.3; P < 0.05).
In conclusion, we have demonstrated a clear diuretic and natriuretic effect of nifedipine in healthy volunteers. The increase of both free water clearance and lithium clearance favours a predominantly proximal site of action. As potassium excretion remained unchanged nifedipine must also interfere with Na+-K+ exchange in the distal tubule. Free water clearance but not lithium clearance allowed us to differentiate between nifedipine and frusemide effects. The reliability of lithium as a marker of proximal tubular sodium reabsorption deserves further investigation. 
